
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members...
- April 28, 2025 01:15 PM PDT
- EODHD

Cincinnati Financial: Q1 Earnings Snapshot
FAIRFIELD, Ohio (AP) — FAIRFIELD, Ohio (AP) — Cincinnati Financial Corp. (CINF) on Monday reported a loss of $90 million in its first quarter. The Fairfield, Ohio-based company said it had a loss of 5...
- April 28, 2025 01:14 PM PDT
- EODHD

Sanmina: Fiscal Q2 Earnings Snapshot
SAN JOSE, Calif. (AP) — SAN JOSE, Calif. (AP) — Sanmina Corp. (SANM) on Monday reported profit of $64.2 million in its fiscal second quarter. On a per-share basis, the San Jose, California-based compa...
- April 28, 2025 01:13 PM PDT
- EODHD

Welltower: Q1 Earnings Snapshot
TOLEDO, Ohio (AP) — TOLEDO, Ohio (AP) — Welltower Inc. (WELL) on Monday reported a key measure of profitability in its first quarter. The results topped Wall Street expectations. The real estate inves...
- April 28, 2025 01:11 PM PDT
- EODHD

Amkor Technology: Q1 Earnings Snapshot
TEMPE, Ariz. (AP) — TEMPE, Ariz. (AP) — Amkor Technology Inc. (AMKR) on Monday reported first-quarter net income of $21.1 million. The Tempe, Arizona-based company said it had net income of 9 cents pe...
- April 28, 2025 01:11 PM PDT
- EODHD

Woodward: Fiscal Q2 Earnings Snapshot
FORT COLLINS, Colo. (AP) — FORT COLLINS, Colo. (AP) — Woodward Inc. (WWD) on Monday reported fiscal second-quarter earnings of $108.9 million. On a per-share basis, the Fort Collins, Colorado-based co...
- April 28, 2025 01:08 PM PDT
- EODHD

CG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer Drug
Shares of CG Oncology catapulted Monday after the biotech unveiled promising results for a J&J-rivaling bladder cancer treatment. Continue Reading View Comments
- April 28, 2025 01:05 PM PDT
- EODHD

IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval
ADMA stock rocketed Monday after the Food and Drug Administration approved its new immunoglobulin production process. Continue Reading View Comments
- April 28, 2025 01:05 PM PDT
- EODHD

Dow, S&P 500 Notch 5-Day Winning Streaks But Nasdaq Falters
The Dow Jones Industrial Average and S&P 500 rose for a fifth day in a row on Monday, but tech stocks struggled ahead of a wave of earnings reports and ended the Nasdaq Composite’s winning streak. The...
- April 28, 2025 01:05 PM PDT
- EODHD

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-e...
- April 28, 2025 01:05 PM PDT
- EODHD